Hurthle Cell Tumor

International Surgery

Volumn 81, Issue 2, 1996, Pages 168-170

  Chen, Huang Yang ^a   Benjamin, Long Bing ^a   Chen, Miin Fu ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Hurtle cell tumors; Thyroid neoplasms

Indexed keywords

ADULT; AGE; ARTICLE; BONE METASTASIS; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LOBECTOMY; MALE; NECK TUMOR; ONCOCYTOMA; THYROID ADENOMA; THYROID CARCINOMA; THYROID TUMOR; THYROIDECTOMY; TUMOR VOLUME;

ADENOCARCINOMA; ADENOMA, OXYPHILIC; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0029908884     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ewing J. Neoplastic disease. 3rd edition. Philadelphia, WB Saunder Co, PA:1928.
2. Gelera H. Hurthle cell and mitochondrial-rich cell tumors: A clinicopathologic study. Cancer 1986;57(6):1154.
3. DeKeyer L, Lagfield L, VanHerle A, Lewin K. Biochemical and immunohistochemical characterization of protein in Hurthle cell carcinoma. J Endocrinol Invest 1984;7(5):449.
4. Gonzales-Campola R, Herrero-Zapatero A, Lerma E, Sanchez F, Galera H. Hurthle cell and mitochondrial rich cell tumors: A clinicopathologic study. Cancer 1986;57:1154.
5. Gundry SR, Burney RD, Thompson NW, Lloyd R. Total thyroidectomy for Hurthle cell neoplasms of the thyroid. Arch Surg 1983;118:529.
6. Thompson NW, Dunn EL, Batsakis JG, Nishiyama RH. Hurthle cell lesions of the thyroid gland. Surg Gynecol Obstet 1974; 139:555.
7. Bondeson L, Bondeson AG, Ljungberg O, Tibblin S. Oxyphil tumors of the thyroid: Follow-up of 42 surgical cases. Ann Surg 1981;194:677.
8. Grant CS, Barr D, Goellner JR, Hay ID. Benign Hurthle cell tumors of the thyroid: A diagnosis to be trusted? World J Surg 1988;12:488.
9. Neslan JM, Sobrinho-Simoes MA, Holm R, Sambade MC, Johannessen JV. Hurthle cell lesions of the thyroid: A combined study using transmission electron microscopy, scanning electron microscopy and immunocytochemistry. Ultrastruct Pathol 1985;8(4):269.
10. Johnson TL, Lloyd RV, Thor A. Expression of ras oncogene p21 antigen in normal and proliferating thyroid tissues. Am J Pathol 1987;127(1):60.
11. Schark C, Fulton N, Jacoby RF, Westbrook CA, Straus II FH, Kaplan EL. N ras 61 oncogene mutations in Hurthle cell tumors. Surgery 1990;108(6):994.
12. Flint A, Davenport RD, Lloyd RV, Beckwith AL, Thompson NW. Cytophotometric measurement of Hurthle cell tumors of the thyroid gland. Correlation with pathological features and clinical behavior Cancer 1988;61(1):110.
13. Ryan JJ, Hay ID, Grant CS et al. Flow cytometric DNA measurement in benign and malignant Hurthle cell tumors of the thyroid. World J Surg 1988;12:482.
14. Gossain AK, Clark OH. Hurthle cell neoplasms: Malignant potential. Arch Surg 1984;119:515.
15. Horn RC. Hurthle cell tumors of the thyroid. Cancer 1954;7:234.
16. Saull SC, Kimmelman CP. Hurthle cell tumors of the thyroid gland. Otolaryngol Head Neck Surg 1985;93:58.
17. Heppe H, Armin A, Calandra DB, Lawrence AM, Palogan E. Hurthle cell tumors of the thyroid gland. Surgery 1985;98:1162.
18. Savino D, Silbey RK, Summer H. Significance of Hurthle cells in thyroid neoplasm: Re-examination of an old but persistent problem. Lab Invest 1981;44:59A.
19. Rosen IB, Luk S, Katz I. Hurthle cell tumor behavior Dilema Resol Surg 1985;98:777.
20. Caplan RH, Abellera RM, Kisten WA. Hurthle cell tumors of the thyroid gland. A clinicopathologic review and long-term follow-up. JAMA 1984;251:3114.
21. Arganini M, Behar R, Wu TC et al. Hurthle cell tumors: A twenty-five year experience. Surgery 1986; 100(6): 1108.
22. Gardner LW, Hurthle cell tumors of the thyroid. Arch Pathol Lab Med 1955;59:372.
23. Miller RH, Estrada R, Sneed WF, Mace ML. Hurthle cell tumor of the thyroid gland. Laryngoscope 1983;93:884.
24. Tollefsen HR, Shah JP, Huvos AG. Hurthle cell carcinoma of the thyroid. Am J Surg 1975;130:390.
25. Watson RG, Brennan MD, Goellner JR, Van Heerden JA, McConahey WM, Taylor WF. Invasive Hurthle cell carcinoma of the thyroid: Natural history and management. Mayo Clin Proc 1984;59:851.
26. Backdahl M, Auer G, Forsslund G et al. Prognostic value of nuclear DNA content in follicular thyroid tumors. Acta Chir Scand 1986;152:1.
27. Wallin G, Backdahl M, Lundell G, Lowhagen T. Nuclear DNA content and prognosis in Hurthle cell tumors of the thyroid gland. Acta Chir Scand 1988;154(9):501.
28. El Naggar AK, Barsakis JG, Luna MA, Hickey RC. Hurthle cell of the thyroid: A flow cytometric DNA analysis. Arch Otolaryngol Head Neck Surg 1988;114:250.
29. Clark OH, Genend PL. Thyrotropin receptor adenyl cyclase system in Hurthle cell neoplasms. J Clin Endocrinol Metab 1985; 61:773.
30. Siperstein A, Zeng QH, Gum E, Levin K, Clark OH. Adenylate cyclase activity as a predictor of thyroid aggressiveness. World J Surg 1988;12:538.
31. Duh QY, Siperstein AE, Miller RA, Smeds S, Clark OH. TSH binding correlates with TSH-stimulated thyroid adenylate cyclase activity in human thyroid tissues. Surgery 1989;106:967.